Neurosciences articles for Germany

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 236

Article ‘Count’ for Neurosciences.

Journal Count Share
1 1.00
Characterising epi-perineurial barrier function by microscale techniques including a miniaturised Ussing chamber 1.00
2 0.57
BLOC1S1 variants cause lysosomal and autophagic defects resulting in a hypomyelinating leukodystrophy with epileptic encephalopathy 0.10
SMN1 variants identified by false-positive SMA newborn screening tests: Therapeutic hurdles and functional and epidemiological solutions 0.47
1 0.44
The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects. 0.44
1 0.50
Modeling Midbrain and Brainstem Neuromelanins to Characterize Metal Binding and Associated MRI Contrast in Parkinson's and Alzheimer's Diseases 0.50
24 11.08
Alzheimer's Disease Co‐Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis 0.98
Cerebrospinal Fluid Amyloid‐β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy 0.91
Multimodal Image Guidance in Subthalamic Deep Brain Stimulation for Parkinson's Disease 0.63
Hyperreflective Foci in the Inner Nuclear Layer: Proof‐of‐Concept for an Optical Coherence Tomography Derived Microglia‐Related Marker in Multiple Sclerosis 1.00
Supratentorial Brain Lesions in Unconscious Patients Map to a Common Human Brain Circuit 0.04
The Clinical Spectrum and Neurodevelopmental Pathogenesis of KPTN-Related Disorder in a Mouse Model 0.09
Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling 0.04
Confined B‐Cell Reconstruction and High T‐Cell Clonality Define Clinical Response to Cladribine Treatment 1.00
<atl>Clinical and Biological Determinants of Longitudinal Cognitive Function in Patients With scp iGBA1/i /scp Variants and Subthalamic Deep Brain Stimulation</atl> 1.00
Probabilistic Lesion Mapping to Optimize Thalamotomy Targets for Focal Hand Dystonia 0.08
<atl>Effects of Intradural Extension of Extracranial Cervical Artery Dissection on Outcomes: A Secondary Analysis From the scpSTOP/scp ‐ scpCAD/scp Study</atl> 0.03
Thrombectomy versus Medical Management for Pediatric Acute Ischemic Stroke Due to Isolated M2 Occlusion: A Multicenter Cohort Study 0.21
Combination of Serum Neurofilament Light Chain and Serum Cardiac Troponin T as Biomarkers Improves Diagnostic Accuracy in Amyotrophic Lateral Sclerosis 1.00
Turning Slowly Predicts Future Diagnosis of Parkinson's Disease: A Decade‐Long Longitudinal Analysis 0.80
Mutations in the Key Autophagy Tethering Factor scpEPG5/scp Link Neurodevelopmental and Neurodegenerative Disorders Including Early‐Onset Parkinsonism 0.18
iHCN2/i‐Associated Neurodevelopmental Disorders: Data from Patients and iXenopus/i Cell Models 0.04
Intravenous Glyburide in Medical and Endovascular‐Treated Large‐Core Stroke: A Subgroup Analysis of the scpCHARM/scp Randomized Clinical Trial 0.06
Phenotypic Changes in a Monocyte Cluster with High Interleukin‐1 Beta Expression during Long‐Term Anti‐scpCD20/scp Therapy 0.18
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1‐Linked Amyotrophic Lateral Sclerosis 0.97
Toward a Universal Map of EEG: A Semantic, Low‐Dimensional Manifold for scpEEG/scp Classification, Clustering, and Prognostication 0.50
The Role of Electroencephalography in Predicting Post-Stroke Seizures and an Updated Prognostic Model (SeLECT-EEG) 0.08
High‐Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis 0.04
Disease Characteristics and Treatments Associated with Outcome in Primary Angiitis of the scpCentral Nervous System/scp—A Multicenter Cohort Study in 163 Patients 1.00
Deep Brain Stimulation for scpiVPS16/i/scp‐Related Dystonia: A Multicenter Study 0.23
1 0.06
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment 0.06
21 8.60
The deep brain stimulation response network in Parkinson’s disease operates in the high beta band 0.62
Clinical-biological Alzheimer’s disease stage concordance: insights from cohorts and autopsy data 0.02
Medial temporal ageing-related tau astrogliopathy below 66 years is associated with neurodegeneration 0.17
Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progression 0.10
Vaccines mimicking conformational epitopes on α-synuclein fibrils provide immunity to Parkinson’s disease 0.55
Multimodal multicentre investigation of diagnostic and prognostic markers in disorders of consciousness 0.22
Treatment evolution in spinal muscular atrophy: insights from the SMArtCARE registry 0.75
A cause and protective treatment for acute and progressive disability and grey matter atrophy 0.13
Somatic gene mutations in the motor cortex of patients with sporadic amyotrophic lateral sclerosis 0.73
Cortical tau deposition promotes atrophy in connected white matter regions in Alzheimer’s disease 0.79
Cerebellar pathology contributes to neurodevelopmental deficits in spinal muscular atrophy 0.65
Tipping the balance: the PD1-axis as modulator in chronic inflammatory demyelinating polyneuropathy 0.96
Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients 0.04
Associations between epilepsy-related polygenic risk and brain morphology in childhood 0.12
Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophy 0.16
Hippocampus and basal forebrain degeneration differentially impact cognition in Lewy body spectrum disorders 1.00
Brain atrophy patterns in anti-IgLON5 disease 0.39
Males but not females report genital sensations evoked by fixed-parameter stimulation of somatosensory cortex 1.00
Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosis 0.07
Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder 0.09
Redefining diagnostic lesional status in temporal lobe epilepsy with artificial intelligence 0.06
1 0.74
Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses 0.74
9 2.07
Physiological brain clearance architecture revealed by neuronal protein tracing 0.19
A causal link between autoantibodies and neurological symptoms in long COVID 0.08
Cell-type resolved protein atlas of brain lysosomes identifies SLC45A1-associated disease as a lysosomal disorder 0.30
Myelin antigen capture in the CNS by B cells expressing EBV latent membrane protein 1 leads to demyelinating lesion formation 0.11
A glycolytic shunt via the pentose phosphate pathway is a metabolic checkpoint for nervous system sensory homeostasis and axonal regeneration 0.05
The effect of shingles vaccination at different stages of the dementia disease course 0.23
Astrocytes functionally integrate multiple synapses via specialized leaflet domains 0.11
Microglia-astrocyte crosstalk regulates synapse remodeling via Wnt signaling 0.05
The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis 0.95
1 0.19
Ferroptosis susceptibility in hippocampal neural precursor cells influences neurogenesis and memory across aging 0.19
1 1.00
Early microglia progenitors colonize the embryonic CNS via integrin-mediated migration from the pial surface 1.00
3 1.41
Single-cell spatial transcriptomic profiling defines a pathogenic inflammatory niche in chronic active multiple sclerosis lesions 0.85
Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosis 0.02
Sensory neurons shape local macrophage identity via TGF-β signaling 0.54
1 0.58
Long-term fasting-induced parasympathetic and sympathetic autonomic nervous system modulation in a subgroup of the GENESIS study 0.58
1 0.60
Multivariate Brain-Blood Signatures in Early-Stage Depression and Psychosis 0.60
3 0.08
Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke 0.02
Tenecteplase for Acute Non–Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke 0.02
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity 0.04
2 1.05
Conformation-specific monoclonal antibodies reveal early Tau structural intermediates in Alzheimer’s disease 0.05
Phosphatidylinositol 3-phosphate metabolism impacts cellular α-synuclein localization in Saccharomyces cerevisiae 1.00
1 0.16
Lysosomal TPC2 channels disrupt Ca2+ entry and dopaminergic function in models of LRRK2-Parkinson’s disease 0.16
5 1.02
Pathogenic variants in BORCS5 Cause a Spectrum of Neurodevelopmental and Neurodegenerative Disorders with Lysosomal Dysfunction 0.05
Inflammasome adaptor ASC promotes sustained neuroinflammation and mild cognitive impairment in a closed-head injury model 0.64
Biallelic variants in ARHGAP19 cause a progressive inherited motor-predominant neuropathy 0.06
Targeting specific kinase substrates rescues increased colitis severity induced by the Crohn’s disease–linked LRRK2-N2081D variant 0.25
Sensory neuron–expressed FGF13 controls nociceptive signaling in diabetic neuropathy models 0.02
1 0.07
TIE2 links MEKK3–KLF2/4 and PI3K signaling in cerebral cavernous malformation 0.07
10 6.09
Transcutaneous auricular vagus nerve stimulation during movement selectively activates motor circuitry without additional cortical or autonomic effects 0.05
Voluntary Dissociation of Motor Unit Activity in the Vastii Muscles 0.83
Motoneurons inhibitory synapses homeostatically respond to neuronal activity and modulate Amyotrophic Lateral Sclerosis pathogenesis 0.73
Quantifying state-dependent control properties of brain dynamics from perturbation responses 0.11
Aperiodic activity reflects pathologic waveform shapes in focal epilepsy 0.80
Rebound Bursting Selectively Enables Fast Dynamics in Dopamine Midbrain Neurons Projecting to the Dorsolateral Striatum 1.00
Origins of the Auditory Brainstem Response in Mice Using Source Localization of Topographic Multichannel EEG 1.00
Spatiotemporal Dynamics of Lateral Na+ Diffusion in Apical Dendrites of Mouse CA1 Pyramidal Neurons 0.71
Multivariate White Matter Microstructure Alterations in Older Adults with Coronary Artery Disease 0.02
ALS mutations shift the isoelectric point of the KIF5A C-terminal inducing protein aggregation and TDP-43 mislocalization 0.83
6 4.48
Neuronal loss of the pentose phosphate pathway in the living nervous system is causally linked to [NADPH] reduction and elevated oxidative stress 1.00
Ageing does not impair motor neuron adaptations: comparable motor unit responses to strength training in young and older adults 0.33
Transport‐related effects on intrinsic and synaptic properties of human cortical neurons: A comparative study 1.00
Hypoxia‐inducible factor‐2 stabilization is not sufficient to induce erythropoietin production in deeper medullary fibroblasts 1.00
Targeting necroptosis protects against astrocyte death and hippocampal sclerosis in experimental temporal lobe epilepsy 1.00
Neural determinants of the increase in muscle strength and force steadiness of the untrained limb following a 4 week unilateral training 0.14
4 2.15
Femtosecond Soft X-ray Absorption Spectroscopy Identifies Metal-Centered S1 Excited State of Cyanocobalamin 0.67
Protein and Solvent Reorganization Drives Radical Pair Stability in Avian Cryptochrome 4a 0.40
Spectroscopic Characterization of Radical Pair Photochemistry in Nonmigratory Avian Cryptochromes: Magnetic Field Effects in GgCry4a 0.38
Small Protein Domains as Potential Spin Labels for In Vitro, Cellular, and Light-Induced Dipolar EPR Spectroscopy 0.70
1 0.56
α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation 0.56
9 4.26
Blood-derived microRNA signatures associated with hippocampal structure and atrophy rate: findings from the Rhineland Study 1.00
Anti-NMDAR encephalitis impairs intrinsic hippocampal dynamics through neuronal hypercoupling, hub dominance, and aberrant ensembles 0.95
Cortical microstructure is associated with disease severity and clinical progression in genetic frontotemporal dementia: a GENFI study 0.09
Gesture deficits in psychosis and the combination of group psychotherapy and transcranial magnetic stimulation: A randomized clinical trial 0.04
Forebrain-specific loss of erythropoietin provokes compensatory upregulation of different EPO receptors 0.95
Frontotemporal dementia patient-derived iPSC neurons show cell pathological hallmarks and evidence for synaptic dysfunction and DNA damage 0.10
The alpha7 nicotinic acetylcholine receptor mediates network dysfunction in a mouse model of local amyloid pathology 0.02
Thalamo-frontal functional connectivity patterns in Tourette Syndrome: Insights from combined intracranial DBS and EEG recordings 0.54
The NMDAR/TRPM4 death complex is a major promoter of disease progression in the 5xFAD mouse model of Alzheimer’s disease 0.57
6 1.39
Sustaining microglial reparative function enhances stroke recovery 0.08
Intestinal macrophages modulate synucleinopathy along the gut–brain axis 0.07
Ageing promotes microglial accumulation of slow-degrading synaptic proteins 0.09
Quantum spin resonance in engineered proteins for multimodal sensing 0.03
Lymphoid gene expression supports neuroprotective microglia function 0.21
Microglia–neuron crosstalk via Hex–GM2–MGL2 maintains brain homeostasis 0.91
1 1.00
Optically detected and radio wave-controlled spin chemistry in flavoproteins 1.00
1 0.85
Riboflavin metabolism shapes FSP1-driven ferroptosis resistance 0.85
39 18.19
Cellular and subcellular heterogeneity of astrocytic Na⁺ homeostasis tuning astrocytes into functionally distinct subgroups in the mouse brain 0.85
Pericytes are organ-specific regulators of tissue morphogenesis 1.00
Nanoscale organization in the cell membrane dynamically modulates the biophysics of voltage-gated sodium channels 0.14
In vivo imaging of central nervous system fluid spaces using synchrotron radiation-based micro computed tomography 0.08
HCN1 is a primary HCN Pacemaker Channel in Neurons 1.00
Oxidative stress causes a reversible decrease of deubiquitylases activity in old vertebrate brains 0.73
Dysfunction of the episodic memory network in the Alzheimer’s disease cascade 0.97
Thyrotropin-releasing hormone neurons of different hypothalamic nuclei increase energy expenditure 0.84
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality 0.10
Dysregulation of macrophage lipid metabolism underlies intracellular bacterial neuroinvasion 0.02
Deep visual proteomics uncovers nociceptor diversity and pain targets 1.00
Exposome-wide patterns predict brain health in aging 0.97
TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation 0.88
Characterizing spatiotemporal white matter hyperintensity pathophysiology in vivo to disentangle vascular and neurodegenerative contributions 0.03
Multi-modal dissection of cell-type specific TDP-43 pathology in the motor cortex 0.85
NF-κB activation in astrocytes impairs wound healing after traumatic brain injury in male mice 0.95
TREM2 expression level is critical for microglial state, metabolic capacity and efficacy of TREM2 agonism 0.84
Intranasal blood-brain barrier bypass enables sequential mitochondria-targeted bioengineered nanolamellar system for ischemic stroke therapy 0.13
Identification of a thermogenic target in the dorsal raphe nucleus for weight management in mice 0.03
Prime editing of the β adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer’s disease 0.02
No causal links between estradiol and female’s brain and mental health using Mendelian randomization 0.07
Structural basis of vilazodone dual binding mode to the serotonin transporter 0.25
Suppression of Huntington’s Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding 0.19
Age modulates the link between stress-related neural activity and mortality 0.07
Astrocytes distress triggers brain pathology through induction of δ secretase in a murine model of Alzheimer’s disease 0.15
Capturing disease severity in LIS1-lissencephaly reveals proteostasis dysregulation in patient-derived forebrain organoids 0.85
Synthetic chaperone based on Hsp90-Tau interaction inhibits Tau aggregation and rescues physiological Tau-Microtubule interaction 0.49
Munc13-1 restoration mitigates presynaptic pathology in spinal muscular atrophy 0.94
Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s Disease 0.03
Integrating artificial intelligence and optogenetics for Parkinson’s disease diagnosis and therapeutics in male mice 0.07
Apelin as a CNS-specific pathway for fenestrated capillary formation in the choroid plexus 1.00
Choroid plexus-mediated CSF secretion remains stable in aging rats via high and age-resistant metabolic activity 0.13
A human brain network linked to restoration of consciousness after deep brain stimulation 0.04
Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer’s disease 0.24
Reduction of neuronal activity mediated by blood-vessel regression in the adult brain 0.06
SEMA3B switches axon-axon to axon-glia interactions required for unmyelinated axon envelopment and integrity 0.08
Cell-specific mechanisms drive connectivity across the time course of Huntington’s disease 0.17
TGFα controls checkpoints in CNS resident and infiltrating immune cells to promote resolution of inflammation 0.93
Concept transfer of synaptic diversity from biological to artificial neural networks 1.00
1 0.03
Genetic modifiers of somatic expansion and clinical phenotypes in Huntington’s disease highlight shared and tissue-specific effects 0.03
4 1.74
Monocyte infiltration induces CNS arginine catabolism to fuel neuroinflammation 0.14
A transcriptomic microglia taxonomy across mouse and human pathologies 0.70
Distinct origins and niches determine the cellular responsiveness of CNS macrophages after repopulation 0.88
Spatial proteomics of Alzheimer’s disease-specific human microglial states 0.02
4 0.40
A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism 0.15
Oral splicing modulator branaplam in Huntington’s disease: a phase 2 randomized controlled trial 0.06
Pridopidine in early-stage manifest Huntington’s disease: a phase 3 trial 0.10
AI-driven reclassification of multiple sclerosis progression 0.09
10 4.42
Investigating the methodological foundation of lesion network mapping 0.17
Sleep-dependent infraslow rhythms are evolutionarily conserved across reptiles and mammals 0.09
Phosphorylated tau exhibits antimicrobial activity capable of neutralizing herpes simplex virus 1 infectivity in human neurons 0.09
A fully iPS-cell-derived 3D model of the human blood–brain barrier for exploring neurovascular disease mechanisms and therapeutic interventions 0.94
Distinct transcriptomic and epigenomic responses of mature oligodendrocytes during disease progression in a mouse model of multiple sclerosis 0.05
A lateral hypothalamic neuronal population expressing leptin receptors counteracts anxiety to enable adaptive behavioral responses 1.00
Region-specific drivers of CSF mobility measured with MRI in humans 0.49
Hormonal milieu influences whole-brain structural dynamics across the menstrual cycle using dense sampling in multiple individuals 0.63
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.09
Response of spatially defined microglia states with distinct chromatin accessibility in a mouse model of Alzheimer’s disease 0.88
1 0.86
Structural analyses define the molecular basis of clusterin chaperone function 0.86
2 0.42
Stochastic misfolding drives the emergence of distinct α-synuclein strains 0.27
The brain neurovascular epigenome and its association with dementia 0.15
1 1.00
Brain-age models with lower age prediction accuracy have higher sensitivity for disease detection 1.00
1 0.21
Two pairs of CACNA1I (CaV3.3) variants with opposite effects on channel function cause neurodevelopmental disorders of varying severity 0.21
15 5.49
The functional impact of LGI1 autoantibodies on human CA3 pyramidal neurons 0.98
Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model 0.02
Fatty acid regulation of feeding in Caenorhabditis elegans reveals the potential ancestral origin of a GLP-1-like multiagonist signaling system 0.14
Immune cell profiling reveals expanded stem cell–like memory T cells in anti-GAD65-associated neurological syndromes 0.86
Phagocytes as plaque catalysts: Human macrophages generate seeding-competent Aβ42 fibrils with cross-seeding activity 0.10
Prevention of ubiquitination at K6 and K9 in mutant huntingtin exacerbates disease pathology in a knock-in mouse model 0.80
Long-term effects of forty-hertz auditory stimulation as a treatment of Alzheimer’s disease: Insights from an aged monkey model study 0.02
Competition between glycine and GABAA receptors for gephyrin controls their equilibrium populations at inhibitory synapses 0.18
Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms 0.23
Characterization of endothelin-converting enzyme 1 as a key enzyme in the multienzyme Aβ degradation pathway 0.05
Full interhemispheric integration sustained by a fraction of posterior callosal fibers 0.50
Higher-order interactions in neuronal function: From genes to ionic currents in biophysical models 0.14
Excitatory glycine receptors control ventral hippocampus synaptic plasticity and anxiety-related behaviors 0.13
Amyloid β–dependent neuronal silencing through synaptic decoupling 0.83
Fluid dynamics model of the cerebral ventricular system 0.50
3 0.71
Reperfusion Therapy in ESCAPE-MeVO Trial Participants: Imaging Characteristics and Clinical Outcomes. 0.12
Brain MRI Analysis of Cumulative Blast Exposure and Intracranial Aneurysms in Special Operations Forces. 0.09
Net Water Uptake at CT Predicts the Treatment Effect of Thrombectomy for Low ASPECTS Stroke. 0.50
3 1.81
Homing pigeon navigation relies on superparamagnetic macrophages under overcast conditions 0.95
A global screen for magnetically induced neuronal activity in the pigeon brain 0.70
Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration 0.16
10 4.82
IgLON5 autoimmune antibodies activate Tau via neuronal hyperactivity 1.00
Broad presence of ferromagnetism in bees and relationship to phylogeny, natural history, and sociality 0.10
VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1–linked Parkinson’s neurons 1.00
The chloride intracellular channel 1 (CLIC1) is essential for microglial morphodynamics and neuroinflammation 0.71
Differential modulation of movement speed with state-dependent deep brain stimulation in Parkinson’s disease 0.83
Excitotoxic neuronal death requires superoxide entry into neurons through volume-regulated anion channels 0.03
Cytoskeletal control in adult microglia is essential to restore neurodevelopmental synaptic and cognitive deficits 0.03
A nut-and-bolt assembly of the bimodular large progenitor botulinum neurotoxin complex 0.50
Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primates 0.08
Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2 0.52
11 5.21
The PET tracer [11C]MODAG-005 targets alpha-synuclein aggregates in the brain 0.93
A platform for near real-time and multiplexed monitoring of cerebrospinal fluid biomarkers and flow in neurocritical care 0.31
Foldamers rescue synucleinopathy phenotypes in multiple in vitro and in vivo models 0.09
Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer’s disease models 0.03
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis 0.23
Brain-derived tau for monitoring brain injury in acute ischemic stroke 0.71
Reconnecting the vagus nerve to the heart through nerve conduit preserves cardiac function in a minipig model of right cardiac vagotomy 0.02
Failure of nerve regeneration in mouse models of diabetes is caused by p35-mediated CDK5 hyperactivity 1.00
Immune signatures link myelin oligodendrocyte glycoprotein antibody–associated disease to other autoantibody-mediated conditions 0.13
SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis 0.82
Hippocampal spreading depolarization as a driver of postictal ambulation 0.95
1 0.86
Direct interaction between TDP-43 and Tau promotes their co-condensation, while suppressing Tau fibril formation and seeding 0.86
1 0.43
A Charge-Reversal Point Mutation Completely Depletes Flavin Chromophore from European Robin Cryptochrome 4a Protein 0.43
2 0.24
Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial 0.17
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication 0.08
5 0.54
Endovascular treatment for medium or distal vessel occlusion stroke (DISTAL): 12-month outcomes of a multicentre, open-label, randomised trial 0.25
Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study 0.08
Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis 0.05
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial 0.08
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study 0.09
2 1.07
The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis 0.07
Theta burst stimulation of temporo-parietal cortex regions for the treatment of persistent auditory hallucinations: a multicentre, randomised, sham-controlled, triple-blind phase 3 trial in Germany 1.00
2 0.18
Asundexian for Secondary Stroke Prevention 0.09
Fremanezumab in Children and Adolescents with Episodic Migraine 0.09

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.